Mercurius BioVentures
Venture capital
UncertainLast verified 6 Nov 2026
Mercurius BioVentures is a Dutch venture capital firm that invests in early-stage biotechnology startups, supporting them from proof of concept through clinical trials.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Pre-seed, Seed
- Sectors
- Biotech & pharma
- Ticket
- €500K–€1M
- Eligible countries
- Not stated
- Provider based in
- Netherlands
- Timing
- Rolling applications
- Focus
- early-stage biotech; academic research valorisation; proof of concept to clinical trials
- How to apply
- Apply route unknown
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Our target is to provide between EUR 500,000 and EUR 1,000,000 of funding per company, which will bring our overall fund to EUR 20,000,000.
https://www.mercuriusbioventures.nl/about-us - Kind
symbolizes our commitment to rapidly advancing biotech startups.
https://www.mercuriusbioventures.nl/home - Sectors
The Netherlands has an enormous potential to become a European leader in biotechnology.
https://www.mercuriusbioventures.nl/about-us - Sectors
transformation within the biotech landscape.
https://www.mercuriusbioventures.nl/home - Stages
specifically the (pre-)seed investment rounds.
https://www.mercuriusbioventures.nl/about-us - Stages
The (pre-)seed phase of a biotech company refers to the very first stage of the company’s creation and development.
https://www.mercuriusbioventures.nl/home - Ticket
provide between EUR 500,000 and EUR 1,000,000 of funding per company
https://www.mercuriusbioventures.nl/about-us - Ticket
provide between EUR 500,000 and EUR 1,000,000 of funding per company
https://www.mercuriusbioventures.nl/about-us
Status history
- 6 Nov 2026: Uncertain (first extraction)
Something wrong or out of date? Report an error.
Work at Mercurius BioVentures? Claim this profile to confirm what you invest in.